Ticker name:TSHATaysha Gene Therapies, Inc.

Country: US-Sector: Healthcare, Industry: Biotechnology

Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.

Market Cap 1.7B

Last close 5.16$

Floor clearance 82.33%

Floor clearance (Past 30d)118.73%

Price Return

90d
-19.63%
YTD
-6.18%
1Y
77.93%
3Y
66.45%
5Y
-74.07%

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA131B516.34$
2REGNREGENERON PHARMACEUTICALS, INC.81B789.45$
3MRNAModerna, Inc.63B158.07$
4RVMDRevolution Medicines, Inc.42B196.94$
5ALNYALNYLAM PHARMACEUTICALS, INC.33B245.51$
6ROIVRoivant Sciences Ltd.29B39.98$
7INSMINSMED Inc27B123.98$
8INCYINCYTE CORP26B127.62$
9UTHRUNITED THERAPEUTICS Corp21B497.27$
10JAZZJazz Pharmaceuticals plc16B243.84$
11ASNDAscendis Pharma A/S16B239.04$
12NBIXNEUROCRINE BIOSCIENCES INC15B151.83$
13EXELEXELIXIS, INC.14B58.49$
14SMMTSummit Therapeutics Inc.14B17.72$
15BBIOBridgeBio Pharma, Inc.13B67.31$
16BMRNBIOMARIN PHARMACEUTICAL INC13B65.08$
17HALOHALOZYME THERAPEUTICS, INC.12B109.68$
18CORTCORCEPT THERAPEUTICS INC12B114.86$
19MDGLMADRIGAL PHARMACEUTICALS, INC.12B534.4$
20TECHBIO-TECHNE Corp11B72.41$